Cargando…
Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell‐free and concentrated ascites reinfusion therapy, in a postmarketing clinical study
Cell‐free and concentrated ascites reinfusion therapy (CART) is performed by collecting the ascites from the patient, followed by filtration and concentration. Thereafter, concentrated cell‐free ascites is reinfused into the patient intravenously. The new type of machine, Plasauto μ, for managing th...
Autores principales: | Hasegawa, Midori, Matsushita, Hiromichi, Yahata, Kensei, Sugawara, Akira, Ishibashi, Yoshitaka, Kawahara, Ryoko, Hamasaki, Yoshifumi, Kanno, Hitoshi, Yamada, Sachie, Nii, Norio, Kato, Masao, Ohashi, Atsushi, Koide, Shigehisa, Hayashi, Hiroki, Yuzawa, Yukio, Tsuboi, Naotake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359940/ https://www.ncbi.nlm.nih.gov/pubmed/33885228 http://dx.doi.org/10.1111/1744-9987.13658 |
Ejemplares similares
-
Ultrastructural observation of filtration membrane in cell‐free and concentrated ascites reinfusion therapy for malignant ascites
por: Koga, Kenichi, et al.
Publicado: (2021) -
Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
por: Miyamoto, Yasunori, et al.
Publicado: (2021) -
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
por: Tsubokura, Misato, et al.
Publicado: (2022) -
Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis
por: Koshi-Ito, Eri, et al.
Publicado: (2021) -
Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure
por: Hsu, Ta-Wei, et al.
Publicado: (2011)